Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer.
biomarkers
cancer
clinical decision-making
hemostasis
prognosis
Journal
Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
revised:
09
09
2022
received:
09
07
2022
accepted:
13
09
2022
pubmed:
16
9
2022
medline:
16
11
2022
entrez:
15
9
2022
Statut:
ppublish
Résumé
Patients with cancer are characterized by a dysregulation of the hemostatic system and systemic hypercoagulability. Different components of the hemostatic system are involved in tumor-promoting mechanisms including primary tumor growth, cancer cell invasion, immune evasion, angiogenesis, and the metastatic process. Therefore, different degrees of systemic hemostatic activation in patients with cancer can reflect distinct underlying biological phenotypes of cancer and seem to correlate with cancer aggressiveness. Peripheral blood levels of hemostatic biomarkers, indicating the activation status of different parts of the hemostatic system including the coagulation cascade, fibrinolytic activity, platelet activation, or endothelial activation, can be used to reflect cancer-associated systemic hypercoagulability. Thereby, hemostatic biomarkers represent promising candidates to investigate as surrogate markers for underlying cancer activity and progression dynamics and therefore as biomarkers for the prediction of clinical outcomes in cancer patients. In the present review, we provide an up-to-date summary of available data on hemostatic biomarkers for prognostication of overall survival and prediction of therapy response in patients with cancer, including specific oncologic treatment settings for potential clinical application. We provide a thorough discussion on potential clinical implementation and current limitations and highlight the most promising emerging biomarkers that might be used to contribute to risk-stratified, personalized oncologic decision making in the future.
Identifiants
pubmed: 36106749
doi: 10.1111/jth.15880
pmc: PMC9827869
pii: S1538-7836(22)18368-6
doi:
Substances chimiques
Hemostatics
0
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2733-2745Informations de copyright
© 2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.
Références
Blood. 2021 Apr 8;137(14):1959-1969
pubmed: 33171494
Nat Med. 1996 Feb;2(2):209-15
pubmed: 8574967
J Thromb Haemost. 2011 Jul;9 Suppl 1:306-15
pubmed: 21781267
Thromb Res. 2014 May;133 Suppl 2:S149-57
pubmed: 24862136
Cancer Metastasis Rev. 2015 Dec;34(4):775-96
pubmed: 26573921
Thromb Haemost. 2016 Apr;115(4):817-26
pubmed: 26738412
Blood. 2016 Jul 7;128(1):24-31
pubmed: 27154188
J Thromb Haemost. 2012 Jul;10(7):1363-70
pubmed: 22520016
Thromb Haemost. 2017 Jan 26;117(2):219-230
pubmed: 27882374
Br J Cancer. 2002 Feb 1;86(3):389-95
pubmed: 11875705
Thromb Res. 2010 Jun;125(6):511-2
pubmed: 19854471
Theranostics. 2019 Sep 23;9(24):7168-7183
pubmed: 31695760
Pharmacol Rep. 2016 Dec;68(6):1140-1148
pubmed: 27588390
Thromb Haemost. 2022 Apr;122(4):633-645
pubmed: 34255340
Cancer Treat Rev. 2015 Dec;41(10):960-70
pubmed: 26604093
Medicine (Baltimore). 2017 Jun;96(25):e7062
pubmed: 28640083
J Thromb Haemost. 2017 Nov;15(11):2208-2217
pubmed: 28834179
BMC Cancer. 2013 Mar 15;13:118
pubmed: 23497249
Haematologica. 2020 Jan;105(1):218-225
pubmed: 31048354
J Clin Oncol. 2000 Feb;18(3):600-8
pubmed: 10653875
Cancer Res. 1996 Nov 1;56(21):5063-70
pubmed: 8895765
Cancer Res. 2011 Oct 15;71(20):6492-502
pubmed: 21880589
Thromb Res. 2020 Jul;191 Suppl 1:S37-S42
pubmed: 32736777
Nat Rev Cancer. 2011 Feb;11(2):123-34
pubmed: 21258396
Thromb Haemost. 2002 Nov;88(5):745-9
pubmed: 12428088
Int J Oncol. 2003 Feb;22(2):295-300
pubmed: 12527925
Eur J Surg Oncol. 2018 Oct;44(10):1494-1503
pubmed: 30100361
J Thromb Haemost. 2016 Feb;14(2):294-305
pubmed: 26662117
Int J Cancer. 2004 Sep 1;111(3):404-8
pubmed: 15221968
World J Gastrointest Surg. 2021 Mar 27;13(3):279-302
pubmed: 33796216
Blood. 2013 Sep 12;122(11):1873-80
pubmed: 23798713
Cancer. 2004 Jul 1;101(1):77-82
pubmed: 15221991
Thromb Res. 2010 Jun;125(6):490-3
pubmed: 20097409
Oncol Rep. 2009 Jun;21(6):1599-604
pubmed: 19424642
Jpn J Clin Oncol. 2001 Aug;31(8):388-94
pubmed: 11574632
Blood. 2021 Jun 10;137(23):3174-3180
pubmed: 33940594
J Thromb Haemost. 2012 Oct;10(10):2027-31
pubmed: 22900573
Blood. 2012 Jan 26;119(4):924-32
pubmed: 22065595
Br J Cancer. 2010 Mar 16;102(6):952-6
pubmed: 20160724
BMC Cancer. 2016 Jul 14;16:480
pubmed: 27418164
Int J Gynecol Cancer. 2015 Jan;25(1):24-32
pubmed: 25347092
Cancers (Basel). 2021 Mar 24;13(7):
pubmed: 33804899
Haematologica. 2012 Aug;97(8):1158-64
pubmed: 22371182
Semin Oncol. 2014 Jun;41(3):311-8
pubmed: 25023347
Pancreatology. 2020 Oct;20(7):1465-1471
pubmed: 32873483
Pancreas. 2014 Jan;43(1):103-8
pubmed: 23921961
Br J Cancer. 2000 Jul;83(2):164-70
pubmed: 10901365
Best Pract Res Clin Haematol. 2009 Mar;22(1):49-60
pubmed: 19285272
J Cancer. 2018 Oct 10;9(21):3904-3911
pubmed: 30410594
Cancers (Basel). 2020 Jun 18;12(6):
pubmed: 32570944
Semin Thromb Hemost. 2008 Mar;34(2):147-53
pubmed: 18645919
J Transl Med. 2018 May 16;16(1):129
pubmed: 29769125
Cancers (Basel). 2019 Dec 14;11(12):
pubmed: 31847343
Cancer Manag Res. 2020 Dec 23;12:13301-13309
pubmed: 33380836
Thromb Res. 2018 Jun;166:54-59
pubmed: 29656167
Arch Intern Med. 2006 Feb 27;166(4):458-64
pubmed: 16505267
Cell Physiol Biochem. 2018;45(4):1663-1676
pubmed: 29490291
Cancer Cell. 2011 Nov 15;20(5):576-90
pubmed: 22094253
Mol Oncol. 2012 Apr;6(2):140-6
pubmed: 22356776
J Thorac Oncol. 2008 Jul;3(7):689-97
pubmed: 18594312
Surg Oncol. 2021 Jun;37:101570
pubmed: 33839443
Clin Chem. 2009 Oct;55(10):1834-42
pubmed: 19661141
Onco Targets Ther. 2019 Nov 19;12:9947-9956
pubmed: 31819491
Cancer Res. 2015 Oct 1;75(19):4235-43
pubmed: 26238780
Haematologica. 2020 Jun;105(6):1704-1711
pubmed: 31558668
Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2837-2847
pubmed: 34470475
Int J Cancer. 2013 Dec 1;133(11):2720-5
pubmed: 23716344
Blood. 2005 Feb 15;105(4):1734-41
pubmed: 15494427
Thromb Res. 2013 Aug;132(2):180-4
pubmed: 23856554
Thromb Res. 2010 Apr;125 Suppl 2:S36-8
pubmed: 20434002
World J Gastroenterol. 2004 Mar 15;10(6):922-3
pubmed: 15040048
Blood. 2017 Sep 28;130(13):1499-1506
pubmed: 28807983
Blood. 2021 Mar 25;137(12):1669-1678
pubmed: 33067632
Breast Cancer Res. 2015 Mar 26;17:44
pubmed: 25882602
Breast Cancer Res. 2013;15(4):207
pubmed: 23905544
Blood. 2005 Jan 1;105(1):178-85
pubmed: 15367435
J Cancer. 2019 Jul 10;10(17):4096-4105
pubmed: 31417654
J Thromb Haemost. 2022 Dec;20(12):2733-2745
pubmed: 36106749
Cancers (Basel). 2020 Sep 03;12(9):
pubmed: 32899157
Thromb Res. 2016 Apr;140 Suppl 1:S55-9
pubmed: 27067979
Cancer. 1992 May 1;69(9):2289-92
pubmed: 1562974
Br J Cancer. 2019 Aug;121(5):359-371
pubmed: 31327867
Ann Transl Med. 2017 Oct;5(20):394
pubmed: 29152494
Medicine (Baltimore). 2015 Feb;94(5):e481
pubmed: 25654390
Thromb Res. 2020 Mar;187:9-17
pubmed: 31945589
J Thromb Haemost. 2018 Mar;16(3):508-518
pubmed: 29325226
Oncol Rep. 2008 Jul;20(1):123-8
pubmed: 18575726
Nat Rev Dis Primers. 2022 Feb 17;8(1):11
pubmed: 35177631
Cancer. 2000 Jan 15;88(2):295-301
pubmed: 10640960
Blood Adv. 2021 Jan 26;5(2):487-495
pubmed: 33496742
Tumour Biol. 2014 Mar;35(3):2103-9
pubmed: 24114016
Eur J Surg Oncol. 2013 Sep;39(9):951-6
pubmed: 23810331
Clin Cancer Res. 2007 May 15;13(10):2870-5
pubmed: 17504985
J Thromb Haemost. 2011 Jan;9(1):57-63
pubmed: 20874781
J Thromb Haemost. 2020 Sep;18(9):2220-2231
pubmed: 32397009
Biomed Pharmacother. 2016 Jul;81:210-217
pubmed: 27261596
Anticancer Res. 2016 Jun;36(6):2933-8
pubmed: 27272807
PLoS One. 2014 Mar 11;9(3):e90547
pubmed: 24618826
Thromb Res. 2017 Jun;154:1-6
pubmed: 28376316
Cancer. 2003 Jun 15;97(12):3044-52
pubmed: 12784340
Blood. 2015 Jul 30;126(5):582-8
pubmed: 26109205
Thromb Res. 2020 Jul;191 Suppl 1:S3-S11
pubmed: 32736775
Medicine (Baltimore). 2015 Jul;94(30):e951
pubmed: 26222870